Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiyoshi Yoshimura

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Plos One|January 11, 2020
High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancerRyotaro Ohkuma, Erica Yada, Shumpei Ishikawa, et al.
Discover Oncology|March 18, 2025
Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8<sup>+</sup> T cells as a predictor of clinical benefitToshiaki Tsurui, Masahiro Hosonuma, Aya Sasaki, et al.
Scientific Reports|October 8, 2024
MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2D<sup>Low</sup> T cellsHitoshi Toyoda, Atsuo Kuramasu, Masahiro Hosonuma, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 25, 2024
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in miceEiji Funayama, Masahiro Hosonuma, Kohei Tajima, et al.
Scientific Reports|May 17, 2024
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibodyMasakazu Murayama, Masahiro Hosonuma, Atsuo Kuramasu, et al.
Frontiers in Immunology|October 4, 2023
Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitorsRyotaro Ohkuma, Sakiko Miura, Satoshi Muto, et al.
Cancer Immunology, Immunotherapy : CII|August 19, 2025
Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunityYoichiro Narikawa, Atsuo Kuramasu, Masahiro Hosonuma, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2024
Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancerKoji Otsuka, Junya Isobe, Yoshiyuki Asai, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Plos One|January 11, 2020
High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancerRyotaro Ohkuma, Erica Yada, Shumpei Ishikawa, et al.
Discover Oncology|March 18, 2025
Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8<sup>+</sup> T cells as a predictor of clinical benefitToshiaki Tsurui, Masahiro Hosonuma, Aya Sasaki, et al.
Scientific Reports|October 8, 2024
MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2D<sup>Low</sup> T cellsHitoshi Toyoda, Atsuo Kuramasu, Masahiro Hosonuma, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 25, 2024
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in miceEiji Funayama, Masahiro Hosonuma, Kohei Tajima, et al.
Scientific Reports|May 17, 2024
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibodyMasakazu Murayama, Masahiro Hosonuma, Atsuo Kuramasu, et al.
Frontiers in Immunology|October 4, 2023
Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitorsRyotaro Ohkuma, Sakiko Miura, Satoshi Muto, et al.
Cancer Immunology, Immunotherapy : CII|August 19, 2025
Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunityYoichiro Narikawa, Atsuo Kuramasu, Masahiro Hosonuma, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2024
Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancerKoji Otsuka, Junya Isobe, Yoshiyuki Asai, et al.
Pageof 11